Ningbo Menovo Pharmaceutical Co., Ltd. (603538)

Overview

Ningbo Menovo Pharmaceutical Co., Ltd. is a dynamic player in the global pharmaceutical industry, specialized in the research, development, production, and distribution of a wide range of pharmaceutical products. Founded in 2004, the company has established its presence in Ningbo, China, where it is headquartered. With a strong focus on the production of active pharmaceutical ingredients (APIs), intermediates, and specialized preparations, Menovo targets various therapeutic areas, including cardiovascular diseases, central nervous system disorders, gastrointestinal tract issues, among others. The company is committed to advancing healthcare through innovation, quality, and effective solutions to improve patient care worldwide.

Products and Services

• Valsartan

  A potent medication utilized in the management of high blood pressure and heart failure, showcasing the commitment of Ningbo Menovo Pharmaceutical Co., Ltd. to address cardiovascular diseases.

• Losartan

  An antihypertensive drug that plays a critical role in the treatment of hypertension and is part of the company's portfolio targeting cardiovascular health.

• Clopidogrel

  As a key antiplatelet medication, it is designed to prevent blood clots, furthering Menovo's focus on cardiovascular wellness and stroke prevention.

• Perindopril

  This ACE inhibitor is primarily used to treat high blood pressure and heart failure, underscoring the firm's dedication to combating heart-related ailments.

• Rosuvastatin Calcium

  A cholesterol-lowering drug that signifies Menovo's active involvement in the battle against hypercholesterolemia and the associated risks of cardiovascular diseases.

• Atorvastatin Calcium

  Part of the statin family, this medication is essential for managing elevated cholesterol levels, highlighting the company's efforts to address heart health and prevent cardiovascular incidents.

• Purin Bahrain

  While not extensively detailed, this product suggests Menovo's venture into innovative compounds, possibly aimed at treating specific conditions or enhancing pharmaceutical efficacy.

Through its diverse product lineup, Ningbo Menovo Pharmaceutical Co., Ltd. demonstrates a comprehensive approach to healthcare, offering APIs, intermediates, and preparations that cater to a wide spectrum of therapeutic areas. The company's dedication to quality, innovation, and patient care drives its operations and contributes to its growing reputation in the pharmaceutical industry.